Company Zealand Pharma A/S

Equities

ZEAL

DK0060257814

Biotechnology & Medical Research

Real-time Estimate Cboe Europe 09:03:12 2024-05-27 EDT 5-day change 1st Jan Change
616 DKK +5.03% Intraday chart for Zealand Pharma A/S -1.53% +64.26%

Business Summary

Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity.

At the end of 2022, the Group had a portfolio of 7 products in clinical development (including 2 in phase III, 3 in phase II and 2 in phase I), and 4 products in preclinical development.

Number of employees: 270

Sales per Business

DKK in Million2022Weight2023Weight Delta
Peptide-based Medicines
100.0 %
104 100.0 % 343 100.0 % +229.65%

Sales per region

DKK in Million2022Weight2023Weight Delta
Germany
85.9 %
-- 294,509 85.9 % -
Denmark
12.9 %
35 33.7 % 44,185 12.9 % +126,142.86%
United States
1.2 %
69 66.3 % 4,094 1.2 % +5,833.33%

Managers

Managers TitleAgeSince
Chief Executive Officer 50 09-12-31
Director of Finance/CFO - 22-10-31
Chief Operating Officer 52 18-02-28
Chief Tech/Sci/R&D Officer 62 22-06-01
Director/Board Member 57 -
Investor Relations Contact - -
General Counsel 56 -
Human Resources Officer 39 19-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 66 19-04-03
Chairman 69 14-12-31
Director/Board Member 68 18-04-18
Director/Board Member 58 19-04-03
Director/Board Member 65 19-04-03
Director/Board Member 57 -
Director/Board Member 55 21-08-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 62,626,184 62,176,860 ( 99.28 %) 351,307 ( 0.5610 %) 99.28 %

Shareholders

NameEquities%Valuation
Van Herk Investments BV
9.950 %
6,233,183 9.950 % 566 M kr
Polar Capital LLP
9.015 %
5,647,561 9.015 % 513 M kr
J.O. Hambro Capital Management Ltd.
4.993 %
3,128,162 4.993 % 284 M kr
MP Investment Management A/S
4.173 %
2,614,590 4.173 % 237 M kr
Nykredit Bank A/S (Investment Management)
0.9496 %
594,915 0.9496 % 54 M kr
373,134 0.5956 % 34 M kr
Fundamental Fondsmæglerselskab A/S
0.4954 %
310,340 0.4954 % 28 M kr
Amundi Asset Management SA (Investment Management)
0.4562 %
285,813 0.4562 % 26 M kr
Danske Bank A/S (Investment Management)
0.4431 %
277,599 0.4431 % 25 M kr
Banque Internationale À Luxembourg SA (Denmark)
0.4378 %
274,263 0.4378 % 25 M kr

Holdings

NameEquities%Valuation
373,134 0.60% 33,861,213 $

Company contact information

Zealand Pharma A/S

Sydmarken 11

2860, Soborg

+45 88 77 36 00

http://www.zealandpharma.com
address Zealand Pharma A/S(ZEAL)
  1. Stock Market
  2. Equities
  3. ZEAL Stock
  4. Company Zealand Pharma A/S